106 related articles for article (PubMed ID: 15910396)
1. Anti-IL-2 receptor antibody vs. polyclonal anti-lymphocyte antibody as induction therapy in pediatric transplantation.
Di Filippo S
Pediatr Transplant; 2005 Jun; 9(3):373-80. PubMed ID: 15910396
[TBL] [Abstract][Full Text] [Related]
2. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
[TBL] [Abstract][Full Text] [Related]
3. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
Swiatecka-Urban A
Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627
[TBL] [Abstract][Full Text] [Related]
4. The role of anti-IL-2 receptor in high-risk kidney transplant patients.
Jirasiritham S; Sumethkul V; Mavichak V; Lertsithichai P; Jirasiritham S
Transplant Proc; 2004 Sep; 36(7):2110-2. PubMed ID: 15518764
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation.
Campara M; Tzvetanov IG; Oberholzer J
Expert Opin Biol Ther; 2010 Jun; 10(6):959-69. PubMed ID: 20415630
[TBL] [Abstract][Full Text] [Related]
6. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
Hardinger KL
Pharmacotherapy; 2006 Dec; 26(12):1771-83. PubMed ID: 17125438
[TBL] [Abstract][Full Text] [Related]
7. Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: a review.
Sandrini S
Clin Transplant; 2005 Dec; 19(6):705-10. PubMed ID: 16313313
[TBL] [Abstract][Full Text] [Related]
8. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
[TBL] [Abstract][Full Text] [Related]
9. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.
Orr DW; Portmann BC; Knisely AS; Stoll S; Rela M; Muiesan P; Bowles MJ; Heaton ND; O'Grady JG; Heneghan MA
Transplant Proc; 2005 Dec; 37(10):4373-9. PubMed ID: 16387124
[TBL] [Abstract][Full Text] [Related]
10. Induction therapy in pediatric kidney transplant recipients discharged with a triple drug immunosuppressive regimen.
Sampaio MS; Poommipanit N; Kuo HT; Reddy PN; Cho YW; Shah T; Bunnapradist S
Pediatr Transplant; 2010 Sep; 14(6):770-8. PubMed ID: 20477974
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 receptor antagonists for pediatric liver transplant recipients: a systematic review and meta-analysis of controlled studies.
Crins ND; Röver C; Goralczyk AD; Friede T
Pediatr Transplant; 2014 Dec; 18(8):839-50. PubMed ID: 25283839
[TBL] [Abstract][Full Text] [Related]
12. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review.
Nashan B
BioDrugs; 2005; 19(1):39-46. PubMed ID: 15691216
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitor minimization in pediatric liver allograft recipients.
Dell-Olio D; Kelly DA
Pediatr Transplant; 2009 Sep; 13(6):670-81. PubMed ID: 19413716
[TBL] [Abstract][Full Text] [Related]
14. Role of anti-interleukin-2 receptor antibodies in kidney transplantation.
Cibrik DM; Kaplan B; Meier-Kriesche HU
BioDrugs; 2001; 15(10):655-66. PubMed ID: 11604047
[TBL] [Abstract][Full Text] [Related]
15. [Anti-CD25 monoclonal antibody against polyclonal antibodies in pediatric renal transplantation].
Zamora I; Berbel O; Simón J; Sanahuja MJ
Nefrologia; 2002; 22(1):66-70. PubMed ID: 11987687
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation.
Taber DJ; Weimert NA; Henderson F; Lin A; Bratton CF; Chavin KD; Baliga PK
Transplant Proc; 2008 Dec; 40(10):3401-7. PubMed ID: 19100399
[TBL] [Abstract][Full Text] [Related]
17. Induction immunotherapy with IL-2Ra monoclonal antibody in kidney transplantation.
Ahsan N
Minerva Urol Nefrol; 2003 Mar; 55(1):67-79. PubMed ID: 12773968
[TBL] [Abstract][Full Text] [Related]
18. Anti-interleukin-2 receptor antibodies in transplantation: what is the basis for choice?
Van Gelder T; Warlé M; Ter Meulen RG
Drugs; 2004; 64(16):1737-41. PubMed ID: 15301558
[TBL] [Abstract][Full Text] [Related]
19. Induction immunosuppression in liver transplantation: a review.
Turner AP; Knechtle SJ
Transpl Int; 2013 Jul; 26(7):673-83. PubMed ID: 23651083
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation.
Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber LW; Gaber AO
Transpl Int; 2001 Dec; 14(6):396-404. PubMed ID: 11793037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
